Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of FGFR2 mRNA | decreases expression | 19933214
|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of FGFR2 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene results in increased expression of FGFR2 mRNA | increases expression | 20406850
|
D000096 |
Acetone |
Acetone results in increased expression of FGFR2 mRNA | increases expression | 12720008
|
C005277 |
alpha-naphthyl thiourea |
alpha-naphthyl thiourea results in increased expression of FGFR2 mRNA | increases expression | 10755703
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of FGFR2 mRNA | affects expression | 16483693
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of FGFR2 mRNA | decreases expression | 15761015
|
D001554 |
Benzene |
Benzene results in increased expression of FGFR2 mRNA | increases expression | 15122651 15120971
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of FGFR2 mRNA | increases expression | 19150397
|
C006780 |
bisphenol A |
bisphenol A affects the expression of FGFR2 mRNA | affects expression | 20170705
|
C487049 |
BXL628 |
BXL628 inhibits the reaction [FGF7 protein results in increased phosphorylation of FGFR2 protein] | decreases reaction|increases phosphorylation | 16289173
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in decreased expression of FGFR2 mRNA | decreases expression | 17484886
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of FGFR2 mRNA | increases expression | 17692400 16644059
|
D004390 |
Chlorpyrifos |
Chlorpyrifos affects the expression of FGFR2 mRNA | affects expression | 18502319
|
D003008 |
Cloprostenol |
Cloprostenol results in increased expression of FGFR2 mRNA | increases expression | 14991729
|
C007164 |
cumene hydroperoxide |
cumene hydroperoxide results in increased phosphorylation of and results in increased activity of FGFR2 protein | increases activity|increases phosphorylation | 12717419
|
D003474 |
Curcumin |
Curcumin results in decreased expression of FGFR2 mRNA | decreases expression | 15713895
|
D003907 |
Dexamethasone |
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FGFR2 mRNA | affects cotreatment|increases expression | 16054899
|
D003907 |
Dexamethasone |
[Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FGFR2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16054899
|
D003907 |
Dexamethasone |
Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FGFR2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16054899
|
D002945 |
Cisplatin |
FGFR2 protein affects the susceptibility to Cisplatin | affects response to substance | 16217747
|
D002117 |
Calcitriol |
Calcitriol results in increased expression of FGFR2 protein | increases expression | 12761878
|
C010452 |
estradiol-17 beta-benzoate |
estradiol-17 beta-benzoate affects the expression of FGFR2 mRNA | affects expression | 15059950
|
C074283 |
estradiol 3-benzoate |
estradiol 3-benzoate results in decreased expression of FGFR2 mRNA alternative form | decreases expression | 15976484
|
C074283 |
estradiol 3-benzoate |
[Progesterone co-treated with estradiol 3-benzoate] results in decreased expression of FGFR2 mRNA alternative form | affects cotreatment|decreases expression | 15976484
|
D004958 |
Estradiol |
ESR2 protein affects the reaction [Estradiol results in decreased expression of FGFR2 mRNA] | affects reaction|decreases expression | 14699072
|
D004958 |
Estradiol |
Estradiol affects the expression of FGFR2 mRNA | affects expression | 14699072
|
D004958 |
Estradiol |
Estradiol results in increased expression of FGFR2 mRNA alternative form | increases expression | 14602803
|
D004958 |
Estradiol |
Estradiol results in increased expression of FGFR2 protein alternative form | increases expression | 18575591
|
D004958 |
Estradiol |
Estradiol results in decreased expression of FGFR2 mRNA alternative form | decreases expression | 15680359
|
D004958 |
Estradiol |
Estradiol results in decreased expression of FGFR2 protein alternative form | decreases expression | 15680359
|
C024552 |
estrone benzoate |
estrone benzoate results in decreased expression of FGFR2 mRNA alternative form | decreases expression | 15120423
|
D000431 |
Ethanol |
Ethanol results in increased expression of FGFR2 mRNA | increases expression | 12720008
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of FGFR2 mRNA | affects expression | 20170705
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of FGFR2 mRNA | affects expression | 20170705
|
D005419 |
Flavonoids |
Flavonoids results in increased expression of FGFR2 mRNA | increases expression | 18035473
|
D005472 |
Fluorouracil |
FGFR2 protein alternative form inhibits the reaction [FGF7 protein results in decreased susceptibility to Fluorouracil] | decreases reaction|decreases response to substance | 18575591
|
C006326 |
fluprostenol |
fluprostenol results in decreased expression of FGFR2 mRNA | decreases expression | 15654655
|
D005576 |
Forskolin |
Forskolin results in increased expression of FGFR2 mRNA | increases expression | 10320526
|
D019307 |
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine |
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Dinoprost affects the localization of FGFR2 protein] | affects localization|decreases reaction | 15654655
|
D006493 |
Heparin |
[Heparin analog binds to FGFR2 protein alternative form] which binds to and results in increased activity of FGF1 protein | affects binding|increases activity | 16219767
|
D006493 |
Heparin |
Heparin promotes the reaction [FGF10 protein binds to FGFR2 protein] | affects binding|increases reaction | 15632068
|
D006493 |
Heparin |
Heparin affects the activity of FGFR2 protein | affects activity | 1373495
|
D006493 |
Heparin |
Heparin promotes the reaction [FGFR2 protein binds to FGF2 protein] | affects binding|increases reaction | 1373495
|
D006493 |
Heparin |
[Heparin binds to FGFR2 protein alternative form] which binds to FGF1 protein | affects binding | 10860838
|
D006493 |
Heparin |
[Heparin binds to FGFR2 protein alternative form] which binds to FGF2 protein | affects binding | 10860838
|
D006493 |
Heparin |
[Heparin binds to FGFR2 protein alternative form] which binds to FGF7 protein | affects binding | 10860838
|
D006493 |
Heparin |
FGF1 protein binds to FGFR2 protein binds to Heparin | affects binding | 16223363 15165853
|
D006497 |
Heparitin Sulfate |
Heparitin Sulfate analog results in decreased activity of FGFR2 protein mutant form | decreases activity | 16373332
|
D006497 |
Heparitin Sulfate |
FGF7 protein binds to Heparitin Sulfate binds to FGFR2 protein alternative form | affects binding | 16315317
|
D006497 |
Heparitin Sulfate |
Heparitin Sulfate analog promotes the reaction [FGF1 protein results in increased activity of FGFR2 protein alternative form] | increases activity|increases reaction | 11714710
|
D006851 |
Hydrochloric Acid |
Hydrochloric Acid results in increased expression of FGFR2 mRNA | increases expression | 15883737
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in decreased expression of FGFR2 mRNA | decreases expression | 17997286
|
D006861 |
Hydrogen Peroxide |
Sodium Selenite promotes the reaction [Hydrogen Peroxide results in decreased expression of FGFR2 mRNA] | decreases expression|increases reaction | 17997286
|
D015056 |
1-Methyl-3-isobutylxanthine |
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FGFR2 mRNA | affects cotreatment|increases expression | 16054899
|
D015056 |
1-Methyl-3-isobutylxanthine |
[Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FGFR2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16054899
|
D015056 |
1-Methyl-3-isobutylxanthine |
Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FGFR2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16054899
|
C533894 |
LG 100815 |
LG 100815 results in increased expression of FGFR2 mRNA | increases expression | 16951191
|
D008044 |
Linuron |
Linuron results in decreased expression of FGFR2 mRNA | decreases expression | 12730624
|
D008770 |
Methylnitrosourea |
Methylnitrosourea results in increased expression of and affects the localization of FGFR2 protein | affects localization|increases expression | 15581186
|
D009151 |
Mustard Gas |
Mustard Gas affects the expression of FGFR2 mRNA | affects expression | 15651846
|
D009151 |
Mustard Gas |
Mustard Gas results in decreased expression of FGFR2 mRNA | decreases expression | 18988085
|
D037742 |
Nanotubes, Carbon |
Nanotubes, Carbon results in increased expression of FGFR2 mRNA | increases expression | 15585362
|
C029938 |
nickel sulfate |
nickel sulfate results in increased expression of FGFR2 protein | increases expression | 12930308
|
D005996 |
Nitroglycerin |
Nitroglycerin results in increased expression of FGFR2 mRNA | increases expression | 12102619
|
C100284 |
norgestomet |
norgestomet results in decreased expression of FGFR2 mRNA alternative form | decreases expression | 10954858
|
C062198 |
octa-2,4,6-trienoic acid |
octa-2,4,6-trienoic acid results in increased expression of FGFR2 mRNA | increases expression | 16951191
|
D009844 |
Oligosaccharides |
Oligosaccharides promotes the reaction [FGF1 protein results in increased activity of FGFR2 protein alternative form] | increases activity|increases reaction | 11714710
|
D009844 |
Oligosaccharides |
Oligosaccharides promotes the reaction [FGF7 protein binds to and results in increased activity of FGFR2 protein alternative form] | affects binding|increases activity|increases reaction | 11714710
|
C030110 |
oxaliplatin |
oxaliplatin results in increased expression of FGFR2 mRNA | increases expression | 17762391
|
D010672 |
Phenytoin |
Phenytoin results in increased expression of FGFR2 mRNA | increases expression | 11352631
|
D010672 |
Phenytoin |
Phenytoin results in increased expression of FGFR2 protein | increases expression | 11352631
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of FGFR2 mRNA | affects binding|increases activity|increases expression | 19710929
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of FGFR2 mRNA | increases expression | 18301758
|
D011374 |
Progesterone |
Progesterone affects the expression of FGFR2 mRNA | affects expression | 17251523
|
D011374 |
Progesterone |
[Progesterone co-treated with estradiol 3-benzoate] results in decreased expression of FGFR2 mRNA alternative form | affects cotreatment|decreases expression | 15976484
|
D011374 |
Progesterone |
Progesterone results in decreased expression of FGFR2 mRNA alternative form | decreases expression | 15120423
|
D015237 |
Dinoprost |
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Dinoprost affects the localization of FGFR2 protein] | affects localization|decreases reaction | 15654655
|
D015237 |
Dinoprost |
Dinoprost affects the localization of [FGF2 protein binds to FGFR2 protein] | affects binding|affects localization | 16365892
|
D015237 |
Dinoprost |
Dinoprost affects the localization of FGFR2 protein | affects localization | 15654655
|
D015237 |
Dinoprost |
Dinoprost promotes the reaction [FGF2 protein binds to FGFR2 protein] | affects binding|increases reaction | 16365892
|
D015237 |
Dinoprost |
Dinoprost results in decreased expression of FGFR2 mRNA | decreases expression | 15654655
|
D015237 |
Dinoprost |
Tetradecanoylphorbol Acetate inhibits the reaction [Dinoprost affects the localization of FGFR2 protein] | affects localization|decreases reaction | 15654655
|
D020849 |
Raloxifene |
[Raloxifene co-treated with ESR2 protein] results in decreased expression of FGFR2 mRNA | affects cotreatment|decreases expression | 19059307
|
D017382 |
Reactive Oxygen Species |
Reactive Oxygen Species results in increased phosphorylation of and results in increased activity of FGFR2 protein | increases activity|increases phosphorylation | 12717419
|
C052785 |
rebamipide |
rebamipide results in increased expression of FGFR2 mRNA | increases expression | 15104358
|
C052785 |
rebamipide |
rebamipide results in increased expression of FGFR2 mRNA alternative form | increases expression | 15104358
|
C089730 |
rosiglitazone |
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FGFR2 mRNA | affects cotreatment|increases expression | 16054899
|
C089730 |
rosiglitazone |
[Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FGFR2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16054899
|
C089730 |
rosiglitazone |
Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FGFR2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16054899
|
D018038 |
Sodium Selenite |
Sodium Selenite promotes the reaction [Hydrogen Peroxide results in decreased expression of FGFR2 mRNA] | decreases expression|increases reaction | 17997286
|
C053081 |
sucrose octasulfate |
sucrose octasulfate binds to FGFR2 protein | affects binding | 15047176
|
D013498 |
Suramin |
Suramin inhibits the reaction [FGF7 protein binds to FGFR2 protein] | affects binding|decreases reaction | 15733146
|
D014284 |
Triiodothyronine |
Triiodothyronine results in increased expression of FGFR2 mRNA | increases expression | 16150908
|
D013629 |
Tamoxifen |
[Tamoxifen co-treated with ESR2 protein] results in decreased expression of FGFR2 mRNA | affects cotreatment|decreases expression | 19059307
|
D013739 |
Testosterone |
Testosterone results in decreased expression of FGFR2 mRNA | decreases expression | 7536664
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FGFR2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16054899
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with EGF protein] results in decreased expression of FGFR2 mRNA | affects cotreatment|decreases expression | 16054899
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FGFR2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16054899
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of FGFR2 mRNA | decreases expression | 17586704 19933214
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of FGFR2 mRNA | increases expression | 16054899
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of FGFR2 mRNA | increases expression | 18796159
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate inhibits the reaction [Dinoprost affects the localization of FGFR2 protein] | affects localization|decreases reaction | 15654655
|
C402769 |
tipifarnib |
tipifarnib results in increased expression of FGFR2 mRNA | increases expression | 16403772
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of FGFR2 mRNA | decreases expression | 7680553
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of FGFR2 protein | decreases expression | 15389522
|
C034028 |
vanadyl sulfate |
vanadyl sulfate results in increased expression of FGFR2 mRNA | increases expression | 16330358
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
3.88 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Ethanol |
10.64 | 18926900 17676605 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenytoin |
10.64 | 10563481 9118846 3425630 6195326 8986270 9677735 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
10.64 | 15322242 14514962 11752688 |
MESH:D000015 |
Abnormalities, Multiple |
marker/mechanism |
|
| 10631169 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
14.11 | 18287403 |
MESH:D000138 |
Acidosis |
|
Ethanol |
14.11 | 11192467 |
MESH:D000138 |
Acidosis |
|
Hydrochloric Acid |
14.11 | 16144966 19262391 12771618 20872349 15920416 11574821 |
MESH:D000141 |
Acidosis, Renal Tubular |
|
Hydrochloric Acid |
5.13 | 17183249 |
MESH:D000142 |
Acidosis, Respiratory |
|
Hydrochloric Acid |
5.14 | 20597076 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.27 | 17505938 |
MESH:D000168 |
Acrocephalosyndactylia |
marker/mechanism |
|
| 9002682 19186770 17694057 9502772 |
MESH:D058186 |
Acute Kidney Injury |
|
Cisplatin |
3.37 | 17670903 12690470 15814532 |
MESH:D055371 |
Acute Lung Injury |
|
Hydrochloric Acid |
11.93 | 16759491 11850527 19060228 19094174 19760209 15970105 11953099 |
MESH:D055371 |
Acute Lung Injury |
|
nickel sulfate |
11.93 | 12718980 19131640 16100012 11954676 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
11.93 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
14.22 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Cisplatin |
14.22 | 17638652 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
14.22 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
14.22 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
14.22 | 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Methylnitrosourea |
14.22 | 15113128 15688392 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
7.73 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
7.73 | 16835633 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Chlorpyrifos |
3.70 | 11874814 16611668 17119214 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
3.97 | 17451421 17308373 |
MESH:D020268 |
Alcohol-Induced Disorders, Nervous System |
|
Ethanol |
4.65 | 15451040 15451039 |
MESH:D019973 |
Alcohol-Related Disorders |
|
Curcumin |
4.41 | 17887948 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.08 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
Curcumin |
5.58 | 15590663 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
5.58 | 15800139 |
MESH:D000544 |
Alzheimer Disease |
|
rosiglitazone |
5.58 | 19621015 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
6.77 | 17963324 15504547 16511603 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
6.77 | 11748828 |
MESH:D000741 |
Anemia, Aplastic |
|
Benzene |
3.85 | 11369114 17661222 14761424 |
MESH:D000844 |
Ankylosis |
marker/mechanism |
|
| 9605588 |
MESH:D000853 |
Anophthalmos |
|
Ethanol |
4.18 | 15513904 |
MESH:D000860 |
Anoxia |
|
Hydrochloric Acid |
4.65 | 15090967 |
MESH:D000987 |
Antisocial Personality Disorder |
|
Testosterone |
5.18 | 7506515 |
MESH:C537780 |
Antley-Bixler syndrome |
marker/mechanism |
|
| |
MESH:D054882 |
Antley-Bixler Syndrome Phenotype |
marker/mechanism |
|
| 9605588 |
MESH:D001008 |
Anxiety Disorders |
|
Ethanol |
3.47 | 11141031 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
2.83 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Dexamethasone |
9.73 | 17659584 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
9.73 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
9.73 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Curcumin |
4.04 | 16807698 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
4.04 | 16292516 |
MESH:D001249 |
Asthma |
|
Mustard Gas |
4.14 | 10378619 |
MESH:D001249 |
Asthma |
|
Tretinoin |
4.14 | 16456186 |
MESH:D050197 |
Atherosclerosis |
|
Curcumin |
5.74 | 18704882 |
MESH:D050197 |
Atherosclerosis |
|
Phenytoin |
5.74 | 15136057 |
MESH:D001327 |
Autoimmune Diseases |
|
Curcumin |
3.85 | 19761891 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
3.78 | 16935849 |
MESH:D001768 |
Blister |
|
Mustard Gas |
4.50 | 19167455 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
22.59 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Hydrochloric Acid |
22.59 | 15920416 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
22.59 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
22.59 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
22.59 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.12 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.31 | 15746008 |
MESH:D001855 |
Bone Marrow Diseases |
|
Benzene |
4.56 | 16183116 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Cisplatin |
4.22 | 14601052 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.27 | 11985600 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
4.67 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
8.84 | 15380490 15845082 15665606 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
8.84 | 16580743 |
MESH:D002545 |
Brain Ischemia |
|
Curcumin |
3.68 | 16770732 |
MESH:D001932 |
Brain Neoplasms |
|
Curcumin |
3.37 | 17596214 |
MESH:D001943 |
Breast Neoplasms |
marker/mechanism |
|
| 17529967 18438407 17529973 |
MESH:D001943 |
Breast Neoplasms |
|
Benzene |
11.01 | 17162533 11921183 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
11.01 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
11.01 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Cisplatin |
11.01 | 18382427 19526202 |
MESH:D001943 |
Breast Neoplasms |
|
Curcumin |
11.01 | 18462866 19250217 16243823 18593918 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
11.01 | 17289903 16675129 17261762 12948864 14630087 19861407 17018787 18497071 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
11.01 | 18608205 16110121 15136595 16557594 19217205 18357371 16595493 |
MESH:D001943 |
Breast Neoplasms |
|
Methylnitrosourea |
11.01 | 16253758 11306469 14633655 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
11.01 | 15562024 16175315 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
11.01 | 16837676 15758505 17242785 15572757 17952589 16912660 17595753 17893378 17440819 15775269 17261762 17049068 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
11.01 | 19288272 20544844 18997820 18351453 21152245 21138602 19103187 11161223 18821012 15668708 17261762 19189212 19200415 19011961 19066611 17893378 20390343 20135344 19487384 19221464 17440819 19410462 17049068 19084267 18984771 19189210 20005174 15565566 20065188 19115204 18425577 18815881 16873071 19142967 20859285 18855134 16818667 16202921 19289846 19244106 17242785 16273361 19059307 18629630 19155303 |
MESH:D001943 |
Breast Neoplasms |
|
Testosterone |
11.01 | 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
11.01 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
11.01 | 16873071 16166294 16443354 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Hydrochloric Acid |
4.06 | 12378975 |
MESH:D001986 |
Bronchial Spasm |
|
Hydrochloric Acid |
4.80 | 15578804 |
MESH:D001989 |
Bronchiolitis Obliterans |
|
Mustard Gas |
4.50 | 15286001 |
MESH:D029481 |
Bronchitis, Chronic |
|
Mustard Gas |
4.31 | 17687719 10378619 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
3.93 | 16813970 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
3.72 | 11589617 |
MESH:D002056 |
Burns |
|
Ethanol |
4.01 | 16374292 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
3.81 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.14 | 18705752 15700767 10355542 15721981 3786805 15673190 16124888 16227642 16097048 16192424 16011737 16050911 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
4.00 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Curcumin |
10.90 | 18593918 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
10.90 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
10.90 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
3.86 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.49 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
19.55 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
19.55 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
19.55 | 15553829 15073043 16217749 11135700 14691202 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
19.55 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cisplatin |
19.55 | 17982673 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
19.55 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Ethanol |
19.55 | 15289165 15763234 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
19.55 | 17088986 16799960 18930000 17045692 17971768 16332177 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
19.55 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
19.55 | 1917145 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.33 | 17123778 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Cisplatin |
4.84 | 12023789 16685392 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Curcumin |
4.84 | 18414057 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.20 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
2.67 | 18695887 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.54 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
14.85 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Cisplatin |
14.85 | 17066447 18337622 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Curcumin |
14.85 | 18462866 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
14.85 | 16280240 17066447 18986760 16757204 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tetradecanoylphorbol Acetate |
14.85 | 18922899 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
14.85 | 16051514 16096774 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
7.59 | 17572228 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
7.59 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Ethanol |
5.50 | 19332462 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
5.50 | 18850075 18670907 16120746 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
5.99 | 16936243 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
5.99 | 15775269 |
MESH:D002386 |
Cataract |
|
Methylnitrosourea |
6.33 | 12484553 |
MESH:D002386 |
Cataract |
|
Tretinoin |
6.33 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
16.11 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
16.11 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Dinoprost |
16.11 | 16192471 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
16.11 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylnitrosourea |
16.11 | 7505956 2727394 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenytoin |
4.66 | 4080065 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
3.93 | 16129372 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Testosterone |
3.40 | 20678186 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.60 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
6.07 | 15861022 17681005 11677210 16105132 17333356 16919318 17110522 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
6.07 | 19176532 |
OMIM:601042 |
CHOREOATHETOSIS/SPASTICITY, EPISODIC |
|
Phenytoin |
5.21 | 11748493 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.49 | 16461808 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.11 | 15894690 |
MESH:D002971 |
Cleft Lip |
marker/mechanism |
|
| 17963255 |
MESH:D002971 |
Cleft Lip |
|
Ethanol |
6.66 | 15513904 |
MESH:D002971 |
Cleft Lip |
|
Phenytoin |
6.66 | 2227380 |
MESH:D002972 |
Cleft Palate |
marker/mechanism |
|
| 17963255 |
MESH:D002972 |
Cleft Palate |
|
Ethanol |
11.45 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Phenytoin |
11.45 | 3877104 2227380 6862529 6856622 10789828 1687470 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
11.45 | 15668235 8697196 12621046 16354765 15340226 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
11.45 | 9407595 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
3.98 | 15800139 |
MESH:D003092 |
Colitis |
|
Curcumin |
7.52 | 16804969 18200517 16782535 |
MESH:D003092 |
Colitis |
|
Tretinoin |
7.52 | 17035595 |
MESH:D003103 |
Coloboma |
|
Curcumin |
9.36 | 18809619 |
MESH:D003103 |
Coloboma |
|
Phenytoin |
9.36 | 9212184 |
MESH:D003110 |
Colonic Neoplasms |
|
Curcumin |
6.94 | 19359593 16340194 |
MESH:D003110 |
Colonic Neoplasms |
|
Dexamethasone |
6.94 | 15824018 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
6.94 | 17169374 17725105 17172411 15001691 18772588 16340194 17287894 16510598 17016597 17018589 |
MESH:D003110 |
Colonic Neoplasms |
|
oxaliplatin |
6.94 | 16004971 16024531 16510598 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
4.12 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
Cisplatin |
4.12 | 15273666 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
4.12 | 15289873 16524972 16282729 18509181 18288408 16303861 17594712 20501625 17094418 15148649 18949393 17695437 17016601 18383874 16391804 17401013 18448328 17454858 16331619 18802399 14970324 17255274 |
MESH:D015179 |
Colorectal Neoplasms |
|
oxaliplatin |
4.12 | 17594712 18509181 17255274 17401013 18448328 17695437 |
MESH:D000013 |
Congenital Abnormalities |
|
Phenytoin |
7.52 | 10627286 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
7.52 | 14669216 17141729 |
MESH:D016510 |
Corneal Neovascularization |
|
Curcumin |
4.25 | 18497527 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
3.56 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
marker/mechanism |
|
| 10631169 16465081 18082115 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
12.30 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Benzene |
12.30 | 15643154 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Dexamethasone |
12.30 | 17728286 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Ethanol |
12.30 | 15513904 19302082 10194807 15451039 11873399 15451040 11198716 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Phenytoin |
12.30 | 9212184 8986270 19952982 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Reactive Oxygen Species |
12.30 | 15736158 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
12.30 | 15322242 10048152 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
12.30 | 9125849 16925845 9664655 17551590 14991402 10589399 8800419 9211117 9224671 9142499 |
MESH:D003394 |
Craniofacial Dysostosis |
marker/mechanism |
|
| 9152842 |
MESH:D003398 |
Craniosynostoses |
marker/mechanism |
|
| 8957519 9605588 16465081 |
OMIM:123790 |
CUTIS GYRATA SYNDROME OF BEARE AND STEVENSON |
marker/mechanism |
|
| 17449949 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
8.77 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
8.77 | 18551238 |
MESH:D003556 |
Cystitis |
|
Hydrochloric Acid |
4.80 | 20719367 12853844 19279288 12599022 |
MESH:D018856 |
Cystitis, Interstitial |
|
Hydrochloric Acid |
5.14 | 17714534 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.13 | 16733453 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.49 | 15213294 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
3.72 | 19031437 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
3.60 | 17474826 |
MESH:D003872 |
Dermatitis |
|
Benzene |
4.13 | 15902427 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dexamethasone |
5.31 | 12438553 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
nickel sulfate |
5.31 | 16780908 16823706 11298694 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.08 | 18249437 |
MESH:D003920 |
Diabetes Mellitus |
|
rosiglitazone |
7.56 | 17446233 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
7.56 | 16285004 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
vanadyl sulfate |
3.83 | 16684804 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Curcumin |
5.97 | 18403477 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
rosiglitazone |
5.97 | 12642470 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
5.97 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Curcumin |
16.85 | 18204486 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
16.85 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
16.85 | 15920148 17308373 17451421 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
16.85 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
3.85 | 17187935 |
MESH:D003967 |
Diarrhea |
|
Dexamethasone |
3.09 | 7237001 |
OMIM:607208 |
DRAVET SYNDROME |
|
Phenytoin |
4.75 | 11748493 |
MESH:D003875 |
Drug Eruptions |
|
Phenytoin |
4.86 | 15024534 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
11.98 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
11.98 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
11.98 | 6623471 17522070 3732212 15968718 15027814 2869522 10092053 10915739 3786805 7440962 19336974 19085960 15998439 4309450 11566570 16177239 7120509 9327722 21278145 16227642 7179309 6884620 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Ethanol |
11.98 | 11566570 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
11.98 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
11.98 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Cisplatin |
6.50 | 15033597 12231392 12649298 19839026 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
6.50 | 11462148 |
MESH:D004381 |
Duodenal Ulcer |
|
Curcumin |
3.43 | 17351913 |
MESH:D004485 |
Eczema |
|
Dexamethasone |
3.84 | 12438553 |
MESH:D004487 |
Edema |
|
Dexamethasone |
23.69 | 19703484 |
MESH:D004487 |
Edema |
|
Mustard Gas |
23.69 | 9260866 11428631 11428647 11402378 |
MESH:D004487 |
Edema |
|
pirinixic acid |
23.69 | 12083418 |
MESH:D004487 |
Edema |
|
Raloxifene |
23.69 | 15860553 |
MESH:D004487 |
Edema |
|
rosiglitazone |
23.69 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
23.69 | 12711302 11000095 |
MESH:D004487 |
Edema |
|
Tetradecanoylphorbol Acetate |
23.69 | 16716910 8273558 15177302 9599246 7812673 8113982 11698051 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
9.72 | 18230668 15322242 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
9.72 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
27.70 | 15138306 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
27.70 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Phenytoin |
27.70 | 17654737 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
27.70 | 17692515 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
27.70 | 15845917 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
27.70 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
9.77 | 18566989 11473722 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
9.77 | 16202921 20544844 19155303 17893378 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
9.77 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
7.02 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
7.02 | 10568697 9294722 |
MESH:D004816 |
Epidermal Necrolysis, Toxic |
|
Phenytoin |
4.57 | 20235791 |
MESH:D004820 |
Epidermolysis Bullosa |
|
Phenytoin |
5.56 | 1399206 6251365 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenytoin |
4.25 | 11558140 17116037 |
MESH:D004827 |
Epilepsy |
|
Phenytoin |
3.56 | 20417680 11434505 821787 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenytoin |
4.66 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenytoin |
4.41 | 3659116 |
MESH:D004890 |
Erythema |
|
Mustard Gas |
4.50 | 9357497 |
MESH:D004935 |
Esophageal Diseases |
|
Hydrochloric Acid |
5.14 | 19566590 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
11.43 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
11.43 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Cisplatin |
11.43 | 15173087 16785472 15464296 16481741 17638652 |
MESH:D004938 |
Esophageal Neoplasms |
|
Ethanol |
11.43 | 16704527 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
11.43 | 16785472 16481741 17638652 16337965 15173087 |
MESH:D004941 |
Esophagitis |
|
Hydrochloric Acid |
5.34 | 12928072 |
MESH:D004942 |
Esophagitis, Peptic |
|
Hydrochloric Acid |
5.35 | 11346197 14621274 20516732 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
7.15 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
7.15 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
38.22 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
38.22 | 12795759 17595544 15959796 19224547 16239168 16045604 12631006 61145 |
MESH:D005234 |
Fatty Liver |
|
Curcumin |
38.22 | 19297423 |
MESH:D005234 |
Fatty Liver |
|
Ethanol |
38.22 | 19236843 18620774 16409862 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
38.22 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
38.22 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
38.22 | 17473493 |
MESH:D005234 |
Fatty Liver |
|
rosiglitazone |
38.22 | 19196556 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
38.22 | 19224547 14986274 |
MESH:D005235 |
Fatty Liver, Alcoholic |
|
Ethanol |
4.99 | 17920746 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
2.80 | 16709447 |
MESH:D005310 |
Fetal Alcohol Syndrome |
|
Ethanol |
4.64 | 10194807 15513904 16946407 15451040 |
MESH:D005313 |
Fetal Death |
|
Phenytoin |
8.61 | 10627286 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
8.61 | 11858732 |
MESH:D005334 |
Fever |
|
Dinoprost |
4.95 | 11852909 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
3.87 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
3.53 | 19069698 |
MESH:D005354 |
Fibrosarcoma |
|
Methylnitrosourea |
4.58 | 11555667 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
21.03 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Curcumin |
21.03 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Hydrochloric Acid |
21.03 | 18497604 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
21.03 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
21.03 | 17994277 |
MESH:D005391 |
Firesetting Behavior |
|
Testosterone |
5.18 | 7506515 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
3.64 | 16904648 |
MESH:D005739 |
Gas Poisoning |
|
Hydrochloric Acid |
4.80 | 12378975 |
MESH:D005756 |
Gastritis |
|
Ethanol |
4.03 | 15046732 |
MESH:D005764 |
Gastroesophageal Reflux |
|
Hydrochloric Acid |
4.70 | 20616304 19957777 20545468 19951613 20516732 12212954 |
MESH:D005770 |
Gastrointestinal Neoplasms |
|
Curcumin |
4.05 | 18462866 |
MESH:D005885 |
Gingival Hyperplasia |
|
Phenytoin |
5.01 | 9029455 |
MESH:D019214 |
Gingival Overgrowth |
|
Phenytoin |
5.56 | 14659971 16390469 |
MESH:D005909 |
Glioblastoma |
|
Curcumin |
9.40 | 17596214 |
MESH:D005909 |
Glioblastoma |
|
Testosterone |
9.40 | 17162496 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
9.40 | 17312396 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
5.34 | 16145905 |
MESH:D005910 |
Glioma |
|
Methylnitrosourea |
5.34 | 9825942 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
3.92 | 10696789 |
MESH:D006223 |
Hamartoma Syndrome, Multiple |
marker/mechanism |
|
| 9002682 |
MESH:D006261 |
Headache |
|
Nitroglycerin |
4.52 | 11554966 11284996 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Cisplatin |
14.63 | 15464296 15102660 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Curcumin |
14.63 | 18829502 18462866 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
14.63 | 18337622 15102660 15162350 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
14.63 | 16096774 |
MESH:D034381 |
Hearing Loss |
|
Cisplatin |
3.74 | 19898482 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.49 | 16084493 |
MESH:D006319 |
Hearing Loss, Sensorineural |
|
Cisplatin |
3.87 | 15464296 |
MESH:D006356 |
Heartburn |
|
Hydrochloric Acid |
5.14 | 19566590 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
5.24 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
5.24 | 9664655 14991402 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.06 | 11110106 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.11 | 20558911 |
MESH:D006402 |
Hematologic Diseases |
|
Benzene |
4.05 | 16183116 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.74 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
2.98 | 19900420 19110552 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
6.15 | 18467677 16221962 19772884 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
6.15 | 15340226 12621046 16120746 |
MESH:D015417 |
Hereditary Sensory and Motor Neuropathy |
|
Curcumin |
4.40 | 17701891 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Dexamethasone |
2.80 | 7520565 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.36 | 15709030 |
MESH:D006628 |
Hirsutism |
|
Testosterone |
4.98 | 17019078 |
MESH:D006689 |
Hodgkin Disease |
|
Cisplatin |
3.06 | 16200630 16170182 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.09 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.38 | 16959395 18606429 16354765 15340226 8697196 |
MESH:D006930 |
Hyperalgesia |
|
Ethanol |
14.43 | 18783367 |
MESH:D006930 |
Hyperalgesia |
|
oxaliplatin |
14.43 | 17418472 |
MESH:D006930 |
Hyperalgesia |
|
rosiglitazone |
14.43 | 12083418 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
14.43 | 16870215 |
MESH:D017588 |
Hyperandrogenism |
|
Testosterone |
4.64 | 17019078 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
3.87 | 16899240 |
MESH:D006937 |
Hypercholesterolemia |
|
Curcumin |
3.47 | 18704882 |
MESH:D006940 |
Hyperemia |
|
Hydrochloric Acid |
4.99 | 12646421 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
3.93 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.61 | 20558911 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Phenytoin |
4.11 | 10459572 |
MESH:D006973 |
Hypertension |
|
Benzene |
9.93 | 17940673 |
MESH:D006973 |
Hypertension |
|
Dexamethasone |
9.93 | 17042910 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
9.93 | 15787275 17577099 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
9.93 | 18850075 18670907 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
9.28 | 15338365 |
MESH:D006975 |
Hypertension, Portal |
|
Hydrochloric Acid |
9.28 | 16984587 |
MESH:D006976 |
Hypertension, Pulmonary |
|
Hydrochloric Acid |
3.97 | 19262391 |
MESH:D007006 |
Hypogonadism |
|
Testosterone |
4.10 | 12002444 |
MESH:D007018 |
Hypopituitarism |
|
Testosterone |
5.53 | 17426086 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.17 | 16945680 16569931 |
MESH:D007022 |
Hypotension |
|
Hydrochloric Acid |
4.16 | 11574821 |
MESH:D007077 |
Ileal Diseases |
|
1-Methyl-3-isobutylxanthine |
4.77 | 18306037 |
MESH:D007174 |
Impulse Control Disorders |
|
Testosterone |
5.18 | 7506515 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
3.76 | 15869954 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
2.86 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
5.40 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
Methylnitrosourea |
5.40 | 7193160 |
MESH:D007249 |
Inflammation |
|
Curcumin |
29.32 | 17151092 18403477 16956363 |
MESH:D007249 |
Inflammation |
|
Dexamethasone |
29.32 | 8960868 11099482 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
29.32 | 17296493 |
MESH:D007249 |
Inflammation |
|
Hydrochloric Acid |
29.32 | 11574821 |
MESH:D007249 |
Inflammation |
|
Mustard Gas |
29.32 | 16001271 9260866 11428647 8975870 11402378 11428620 11428631 17524151 9357497 |
MESH:D007249 |
Inflammation |
|
Progesterone |
29.32 | 15869954 |
MESH:D007249 |
Inflammation |
|
rosiglitazone |
29.32 | 12083418 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
29.32 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
29.32 | 12200463 12878042 |
MESH:D007249 |
Inflammation |
|
Tetradecanoylphorbol Acetate |
29.32 | 11698051 8273558 7562506 7812673 15177302 |
MESH:D015212 |
Inflammatory Bowel Diseases |
|
Curcumin |
2.90 | 18200517 18596194 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
18.35 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
18.35 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
18.35 | 16306350 |
MESH:D007333 |
Insulin Resistance |
|
rosiglitazone |
18.35 | 16306350 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
18.35 | 14714311 |
MESH:D007410 |
Intestinal Diseases |
|
Hydrochloric Acid |
13.01 | 11574821 |
MESH:D007410 |
Intestinal Diseases |
|
rebamipide |
13.01 | 11686837 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
13.01 | 17994277 |
MESH:D007414 |
Intestinal Neoplasms |
|
Curcumin |
3.64 | 10783313 |
MESH:D002532 |
Intracranial Aneurysm |
|
Reactive Oxygen Species |
4.41 | 19381132 |
MESH:C537559 |
Jackson-Weiss syndrome |
marker/mechanism |
|
| |
MESH:D007569 |
Jaw Abnormalities |
|
Ethanol |
13.76 | 15513904 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
13.76 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
13.76 | 15992940 17551590 |
MESH:D007579 |
Jejunal Diseases |
|
1-Methyl-3-isobutylxanthine |
4.77 | 18306037 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Cisplatin |
4.47 | 15464296 |
MESH:D007674 |
Kidney Diseases |
|
Cisplatin |
4.90 | 18289764 12649298 15190930 12231392 19839026 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
4.90 | 15618244 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
3.68 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
17.61 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
17.61 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
17.61 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
17.61 | 16985049 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
17.61 | 18625569 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Cisplatin |
4.13 | 11231351 |
MESH:C538132 |
Lacrimoauriculodentodigital syndrome |
marker/mechanism |
|
| |
MESH:D007818 |
Laryngeal Diseases |
|
Hydrochloric Acid |
5.69 | 16498863 |
MESH:D007826 |
Laryngismus |
|
Hydrochloric Acid |
5.69 | 11510729 |
MESH:D007859 |
Learning Disorders |
|
Ethanol |
3.58 | 15451040 |
MESH:D007889 |
Leiomyoma |
|
Curcumin |
9.13 | 18555241 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
9.13 | 16973256 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
11.93 | 15070760 |
MESH:D007938 |
Leukemia |
|
Benzene |
11.93 | 18335105 15935818 14694614 17119257 |
MESH:D007938 |
Leukemia |
|
Curcumin |
11.93 | 18462866 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
11.93 | 17143497 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
7.80 | 17077332 12560223 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Curcumin |
7.80 | 16106398 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
3.65 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
2.93 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
12.63 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
Benzene |
12.63 | 17506065 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
12.63 | 16482212 19285840 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
5.20 | 16467208 16968895 19850784 17050201 20471514 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Benzene |
5.20 | 19478238 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
5.20 | 16294345 17596541 19850784 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
6.11 | 11161223 9834237 15336539 16112521 16330433 15213294 17869043 17649720 12679006 19642359 15622746 17712046 19225113 16823087 16966277 12712474 15748426 11468182 19035177 17107899 16331271 16891316 12018890 19075265 17217047 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
6.11 | 16891316 17368321 17107899 16766008 19075265 15748426 17361223 17217047 16788101 16331271 17712046 19225113 19035177 17301526 17649720 19029980 17294898 16140955 19642359 17506722 9834237 12679006 17339181 16935935 16823087 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
9.64 | 16882451 |
MESH:D015458 |
Leukemia, T-Cell |
|
Curcumin |
9.64 | 16106398 |
MESH:D017880 |
Limb Deformities, Congenital |
marker/mechanism |
|
| 10631169 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Ethanol |
10.96 | 17676605 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Methylnitrosourea |
10.96 | 15526292 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
10.96 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
2.67 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
marker/mechanism |
|
| 17692400 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
8.91 | 11903743 16239168 16943688 16221502 17334410 17157831 11408273 21278145 17174718 |
MESH:D008103 |
Liver Cirrhosis |
|
Ethanol |
8.91 | 15289165 |
MESH:D008103 |
Liver Cirrhosis |
|
Hydrochloric Acid |
8.91 | 16984587 |
MESH:D008104 |
Liver Cirrhosis, Alcoholic |
|
Ethanol |
4.44 | 18295389 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
17.91 | 17557913 16192424 12666154 15876570 14620537 12445421 17481882 16027843 12389079 20821823 18472094 12632512 17922224 18205269 12898905 15052691 17698563 16248980 17761835 15996030 15818738 18187930 15673190 16116963 17708605 12741479 12632514 18481824 12546737 12609069 15931870 18395095 15370692 18412020 14512876 17631135 17823541 17900296 17869086 12958196 14716496 18705752 12445418 15338365 15730626 16097048 17714472 17721639 18054572 18156304 18376398 17766677 16136751 12586293 18251166 18317297 15925388 15057751 12649538 10355542 18395914 14724832 16638106 17944888 18006644 18166357 17976157 18210741 18277467 15123356 18263696 18339082 14748882 11481614 14716833 15893842 18472332 16033810 16015684 17565644 16011737 15362042 15959796 18429990 18418968 13678700 17805973 15650968 18420326 12667390 18279442 17525996 17640975 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Curcumin |
17.91 | 17355460 18705752 18006644 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dexamethasone |
17.91 | 16718785 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
17.91 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Ethanol |
17.91 | 18166357 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Heparin |
17.91 | 16904936 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
17.91 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
rosiglitazone |
17.91 | 17347453 15980055 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
17.91 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
17.91 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
17.91 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
7.64 | 15720792 16964402 17285989 16246199 15830285 |
MESH:D008107 |
Liver Diseases |
|
Chlorpyrifos |
7.64 | 15991261 |
MESH:D008107 |
Liver Diseases |
|
Curcumin |
7.64 | 16956363 |
MESH:D008107 |
Liver Diseases |
|
Phenytoin |
7.64 | 14986274 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Ethanol |
4.01 | 17347304 17207112 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.52 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.11 | 14706259 16899240 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
17.24 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
17.24 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
17.24 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
17.24 | 18383874 17045692 15113037 16603448 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
17.24 | 20007298 16377806 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
17.24 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
17.24 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
13.98 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
13.98 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Benzene |
13.98 | 12562636 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
13.98 | 15583823 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
13.98 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
2.84 | 15213294 |
MESH:D038061 |
Lower Extremity Deformities, Congenital |
|
Methylnitrosourea |
4.82 | 16080182 |
MESH:D008171 |
Lung Diseases |
|
Hydrochloric Acid |
6.40 | 16784557 |
MESH:D008171 |
Lung Diseases |
|
Mustard Gas |
6.40 | 18161513 18702808 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Benzene |
4.14 | 14698565 |
MESH:D055370 |
Lung Injury |
|
Hydrochloric Acid |
4.13 | 19262391 16129981 21114838 18573544 18497604 18339021 19644408 15044056 17627322 15090967 21311175 11395602 20597076 15607125 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
20.03 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Benzene |
20.03 | 12562636 |
MESH:D008175 |
Lung Neoplasms |
|
Cisplatin |
20.03 | 11798837 6189445 17225452 |
MESH:D008175 |
Lung Neoplasms |
|
Curcumin |
20.03 | 19359593 18462866 16243823 |
MESH:D008175 |
Lung Neoplasms |
|
Dexamethasone |
20.03 | 15824018 11195469 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
20.03 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Methylnitrosourea |
20.03 | 18062963 |
MESH:D008175 |
Lung Neoplasms |
|
Mustard Gas |
20.03 | 8781369 3148597 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
20.03 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
20.03 | 11884234 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
Tetradecanoylphorbol Acetate |
20.03 | 11807781 |
MESH:D008175 |
Lung Neoplasms |
|
tipifarnib |
20.03 | 16885199 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.13 | 15086387 |
MESH:D008223 |
Lymphoma |
|
Benzene |
9.93 | 17119257 17584886 |
MESH:D008223 |
Lymphoma |
|
Curcumin |
9.93 | 18462866 |
MESH:D008223 |
Lymphoma |
|
Methylnitrosourea |
9.93 | 16257854 11418001 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Methylnitrosourea |
8.43 | 14633661 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
8.43 | 14737004 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Curcumin |
4.05 | 16173963 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Benzene |
7.90 | 12562636 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
7.90 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Benzene |
29.80 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
29.80 | 11807958 16891317 17203775 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
estradiol 3-benzoate |
29.80 | 15375486 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Methylnitrosourea |
29.80 | 15313902 19196723 11751437 16051031 10767621 14999141 16619500 17020996 12931682 15688392 15113128 10838139 11807958 17131329 14633655 16827153 16944150 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
29.80 | 17203775 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
rosiglitazone |
29.80 | 16827153 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
29.80 | 14580682 19196723 11731420 16827153 19196722 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tetradecanoylphorbol Acetate |
29.80 | 8985016 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
tipifarnib |
29.80 | 16648579 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
10.42 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
10.42 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.48 | 17453147 |
MESH:D008545 |
Melanoma |
|
Cisplatin |
8.05 | 12374674 16809738 12883367 16432458 18332650 15577323 11135225 12393984 18176117 18505091 17761969 17023156 16248763 |
MESH:D008545 |
Melanoma |
|
Curcumin |
8.05 | 17885582 18462866 |
MESH:D008545 |
Melanoma |
|
Reactive Oxygen Species |
8.05 | 17992120 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
8.05 | 19393235 12393984 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
8.05 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Cisplatin |
9.33 | 15990972 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
9.33 | 15990972 |
MESH:D008569 |
Memory Disorders |
|
Curcumin |
7.69 | 17263510 |
MESH:D008569 |
Memory Disorders |
|
Ethanol |
7.69 | 18411066 15451040 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
3.78 | 16940565 |
MESH:D008607 |
Mental Retardation |
marker/mechanism |
|
| 16465081 |
MESH:D008607 |
Mental Retardation |
|
Phenytoin |
3.41 | 9212184 |
MESH:D008654 |
Mesothelioma |
|
Cisplatin |
2.94 | 17638057 |
MESH:D024821 |
Metabolic Syndrome X |
|
rosiglitazone |
3.83 | 17261469 |
MESH:D008708 |
Methemoglobinemia |
|
Nitroglycerin |
4.13 | 3537620 |
MESH:D020326 |
Migraine without Aura |
|
Nitroglycerin |
4.50 | 14659530 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
4.88 | 15863610 |
MESH:D019957 |
Motor Skills Disorders |
marker/mechanism |
|
| 16465081 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.12 | 18986760 16757204 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
17.50 | 15949261 19417148 19549372 11468182 14977855 |
MESH:D009101 |
Multiple Myeloma |
|
Benzene |
17.50 | 17119195 |
MESH:D009101 |
Multiple Myeloma |
|
Curcumin |
17.50 | 19372569 |
MESH:D009101 |
Multiple Myeloma |
|
Dexamethasone |
17.50 | 16118317 15867202 15744524 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
17.50 | 16497877 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
Curcumin |
4.26 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
2.87 | 16239165 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.00 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
9.96 | 16882451 16105982 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Dexamethasone |
9.96 | 9809623 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
9.96 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Hydrochloric Acid |
7.84 | 18534312 |
MESH:D009203 |
Myocardial Infarction |
|
Nitroglycerin |
7.84 | 14729435 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
7.84 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.49 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
6.53 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
6.53 | 16411023 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenytoin |
4.87 | 17484760 |
MESH:D009224 |
Myotonia Congenita |
|
Phenytoin |
4.75 | 1896199 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
4.88 | 16343187 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
8.17 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
8.17 | 7678174 18551238 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
8.25 | 16624393 |
MESH:D009361 |
Neoplasm Invasiveness |
|
Curcumin |
8.25 | 18495463 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.25 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.26 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Cisplatin |
11.81 | 16773208 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
11.81 | 18239605 18600527 16928823 |
MESH:D009369 |
Neoplasms |
|
Methylnitrosourea |
11.81 | 15533788 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
11.81 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
11.81 | 16594593 16946489 |
MESH:D009374 |
Neoplasms, Experimental |
|
Methylnitrosourea |
3.84 | 12696579 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Curcumin |
8.62 | 12497104 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
8.62 | 19200415 19196722 19189210 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.08 | 17289903 |
MESH:D009395 |
Nephritis, Interstitial |
|
Cisplatin |
3.83 | 15464296 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
18.33 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
18.33 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
18.33 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
18.33 | 9125849 |
MESH:D009423 |
Nervous System Neoplasms |
|
Curcumin |
4.96 | 18462866 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
13.65 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
Benzene |
13.65 | 15643154 |
MESH:D009436 |
Neural Tube Defects |
|
Phenytoin |
13.65 | 9118846 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
13.65 | 9142499 |
MESH:D009442 |
Neurilemmoma |
|
Methylnitrosourea |
4.83 | 11555667 |
MESH:D009447 |
Neuroblastoma |
|
Cisplatin |
3.07 | 8761367 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cisplatin |
4.04 | 8761367 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Chlorpyrifos |
6.74 | 15081274 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
6.74 | 16436463 |
MESH:D009503 |
Neutropenia |
|
Mustard Gas |
3.37 | 16761898 7688884 |
MESH:D009765 |
Obesity |
|
Curcumin |
3.89 | 19297423 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
3.89 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
16.95 | 12819281 16049721 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
16.95 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
Benzene |
16.95 | 17119257 15612468 17178637 15935809 17479406 15727169 15576619 16737584 15913788 |
MESH:D009784 |
Occupational Diseases |
|
Hydrochloric Acid |
16.95 | 12378975 |
MESH:D010018 |
Osteomalacia |
|
Phenytoin |
4.75 | 17016548 |
MESH:D010024 |
Osteoporosis |
|
Curcumin |
5.96 | 18719352 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
5.96 | 17882678 19059307 15775268 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
3.62 | 17893378 15579764 15758505 17823083 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.33 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
18.90 | 16624393 12452020 19769630 |
MESH:D010051 |
Ovarian Neoplasms |
|
Benzene |
18.90 | 12562636 |
MESH:D010051 |
Ovarian Neoplasms |
|
Cisplatin |
18.90 | 6897625 19769630 15464296 17225452 |
MESH:D010051 |
Ovarian Neoplasms |
|
Curcumin |
18.90 | 19020741 18462866 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
18.90 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
18.90 | 17393432 16525653 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
18.90 | 16936753 |
MESH:D010146 |
Pain |
|
Phenytoin |
5.41 | 15215642 |
MESH:D010146 |
Pain |
|
Tretinoin |
5.41 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
28.25 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cisplatin |
28.25 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Curcumin |
28.25 | 17440100 19196508 19401701 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Ethanol |
28.25 | 12384795 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
28.25 | 19003803 16929163 15113037 16500647 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Methylnitrosourea |
28.25 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Reactive Oxygen Species |
28.25 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tetradecanoylphorbol Acetate |
28.25 | 15976015 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
28.25 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.08 | 11578682 |
MESH:D010212 |
Papilloma |
|
cumene hydroperoxide |
12.19 | 17234724 12065085 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
12.19 | 12065085 |
MESH:D010212 |
Papilloma |
|
Tetradecanoylphorbol Acetate |
12.19 | 12065085 18404319 18922899 8330346 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.55 | 19927285 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.58 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Cisplatin |
3.69 | 15464296 |
MESH:D049068 |
Plagiocephaly, Nonsynostotic |
marker/mechanism |
|
| 9152842 |
MESH:D010997 |
Pleural Neoplasms |
|
Cisplatin |
4.67 | 17638057 |
MESH:D011015 |
Pneumonia, Aspiration |
|
Hydrochloric Acid |
4.72 | 15970105 18497604 18573544 15607125 |
MESH:D011041 |
Poisoning |
|
Mustard Gas |
3.20 | 15727166 |
MESH:D017689 |
Polydactyly |
|
Phenytoin |
4.48 | 9212184 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
2.93 | 18163543 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Dexamethasone |
3.14 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
7.34 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
7.34 | 11896295 11399792 11118676 11222880 |
MESH:D011470 |
Prostatic Hyperplasia |
|
BXL628 |
10.79 | 16957418 15572423 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
10.79 | 15572423 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
14.63 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
14.63 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Testosterone |
14.63 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
3.10 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
3.10 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
3.10 | 16289102 15754350 18247401 12479363 16644109 |
MESH:D011471 |
Prostatic Neoplasms |
|
Curcumin |
3.10 | 18156803 10851300 11398177 15129424 12497104 18226269 18769126 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.10 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
3.10 | 18626508 19082440 |
MESH:D011471 |
Prostatic Neoplasms |
|
Methylnitrosourea |
3.10 | 15682402 12376480 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
3.10 | 15731164 16220300 16536755 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
3.10 | 18760546 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
3.10 | 15067354 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.00 | 16636307 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
7.36 | 16919318 15861022 |
MESH:D011537 |
Pruritus |
|
Mustard Gas |
7.36 | 18058305 |
MESH:D019310 |
Pseudolymphoma |
|
Phenytoin |
4.87 | 12752131 1419762 8603615 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.13 | 16723453 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.13 | 10548101 |
MESH:D001261 |
Pulmonary Atelectasis |
|
Hydrochloric Acid |
5.35 | 20597076 |
MESH:D011654 |
Pulmonary Edema |
|
Hydrochloric Acid |
4.55 | 15090967 |
MESH:D011656 |
Pulmonary Emphysema |
|
Curcumin |
3.95 | 19168576 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Mustard Gas |
2.64 | 17620002 10334151 17720292 17894541 17266442 |
MESH:D011693 |
Purpura |
|
Raloxifene |
4.88 | 15770314 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.45 | 15538739 16160472 18286688 18722050 |
MESH:D051437 |
Renal Insufficiency |
|
Cisplatin |
3.77 | 15464296 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.03 | 19058328 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Curcumin |
11.87 | 18379247 10666014 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Dexamethasone |
11.87 | 18379247 11700416 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Hydrochloric Acid |
11.87 | 17627322 18339021 16784557 18549715 16129981 |
MESH:D012133 |
Respiratory Paralysis |
|
Hydrochloric Acid |
5.69 | 11510729 |
MESH:D012135 |
Respiratory Sounds |
|
Chlorpyrifos |
4.00 | 16611668 17119214 11874814 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.21 | 18990726 |
MESH:D012140 |
Respiratory Tract Diseases |
|
Chlorpyrifos |
8.92 | 16611668 17119214 |
MESH:D012140 |
Respiratory Tract Diseases |
|
Hydrochloric Acid |
8.92 | 20516732 |
MESH:D012162 |
Retinal Degeneration |
|
Methylnitrosourea |
3.90 | 18155124 18172121 |
MESH:D012175 |
Retinoblastoma |
|
Methylnitrosourea |
4.83 | 11555667 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.49 | 16283617 16116481 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.58 | 18045962 |
MESH:D012509 |
Sarcoma |
|
Curcumin |
3.54 | 18462866 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
8.27 | 16646077 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Cisplatin |
8.27 | 14601052 |
OMIM:609579 |
SCAPHOCEPHALY, MAXILLARY RETRUSION, AND MENTAL RETARDATION |
marker/mechanism |
|
| |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
10.29 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
10.29 | 18551238 |
MESH:D012640 |
Seizures |
|
Ethanol |
10.29 | 9754883 |
MESH:D012640 |
Seizures |
|
Phenytoin |
10.29 | 19919933 10029267 3691417 3137016 9844417 11044598 16876388 15946322 |
MESH:D018805 |
Sepsis |
|
Curcumin |
3.53 | 18389075 |
MESH:D012729 |
Sex Chromosome Aberrations |
|
Chlorpyrifos |
5.42 | 6418539 |
MESH:D012735 |
Sexual Dysfunction, Physiological |
|
Testosterone |
5.53 | 16631401 |
MESH:D012851 |
Sinus Thrombosis, Intracranial |
|
Heparin |
5.41 | 12269725 |
MESH:D012868 |
Skin Abnormalities |
marker/mechanism |
|
| 10631169 |
MESH:D012871 |
Skin Diseases |
|
Mustard Gas |
2.51 | 12880345 15451306 16961503 |
MESH:D012878 |
Skin Neoplasms |
|
cumene hydroperoxide |
14.17 | 12065085 17234724 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
14.17 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
14.17 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tetradecanoylphorbol Acetate |
14.17 | 18404319 8985016 8330346 12065085 11807781 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
14.17 | 16467112 |
MESH:D055752 |
Small Cell Lung Carcinoma |
|
Cisplatin |
4.67 | 15464296 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
9.34 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
9.34 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
8.70 | 16503802 15862959 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
8.70 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
marker/mechanism |
|
| 9605588 |
MESH:D013262 |
Stevens-Johnson Syndrome |
|
Phenytoin |
4.51 | 20235791 |
MESH:D013272 |
Stomach Diseases |
|
Dexamethasone |
8.51 | 15472012 |
MESH:D013272 |
Stomach Diseases |
|
rebamipide |
8.51 | 16184426 |
MESH:D013274 |
Stomach Neoplasms |
marker/mechanism |
|
| |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
10.81 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzene |
10.81 | 12562636 |
MESH:D013274 |
Stomach Neoplasms |
|
Cisplatin |
10.81 | 15958060 18396642 17522103 |
MESH:D013274 |
Stomach Neoplasms |
|
Ethanol |
10.81 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
10.81 | 17522103 15786421 16424979 17498489 16951190 18396642 19015929 19084572 18567086 17172411 |
MESH:D013274 |
Stomach Neoplasms |
|
Methylnitrosourea |
10.81 | 16257854 18593901 15930296 |
MESH:D013274 |
Stomach Neoplasms |
|
rebamipide |
10.81 | 15993841 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
10.81 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
Curcumin |
12.48 | 19188055 16631530 |
MESH:D013276 |
Stomach Ulcer |
|
Dexamethasone |
12.48 | 15138204 |
MESH:D013276 |
Stomach Ulcer |
|
Ethanol |
12.48 | 9211565 16755016 17189318 11906479 9562338 17918041 |
MESH:D013276 |
Stomach Ulcer |
|
Hydrochloric Acid |
12.48 | 17189318 15309881 16755016 |
MESH:D020521 |
Stroke |
|
Raloxifene |
3.29 | 16837676 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.33 | 16045194 16684133 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Ethanol |
3.68 | 9754883 |
MESH:D013736 |
Testicular Neoplasms |
|
Cisplatin |
4.02 | 15464296 17225452 |
MESH:D013921 |
Thrombocytopenia |
|
Heparin |
4.88 | 16893407 16651880 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.01 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
7.63 | 15669648 |
MESH:D013927 |
Thrombosis |
|
Heparin |
7.63 | 16893407 |
MESH:D013953 |
Thymus Neoplasms |
|
Benzene |
10.05 | 10850423 |
MESH:D013953 |
Thymus Neoplasms |
|
Methylnitrosourea |
10.05 | 11418001 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.23 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
9.14 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Methylnitrosourea |
9.14 | 7505956 3078959 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
9.14 | 16026305 17045167 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
11.49 | 19048282 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
11.49 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
7.91 | 16280240 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
7.91 | 16051514 |
MESH:D014071 |
Tooth Abnormalities |
marker/mechanism |
|
| 10631169 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.31 | 15213294 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
2.79 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
19.37 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
19.37 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
19.37 | 11780464 12845720 12973940 20435036 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cisplatin |
19.37 | 12973940 17225452 15464296 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Curcumin |
19.37 | 18593936 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
19.37 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
19.37 | 17572228 8653321 16712894 |
MESH:D014565 |
Urogenital Neoplasms |
|
Curcumin |
4.61 | 18462866 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
9.81 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
9.81 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Cisplatin |
12.59 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
12.59 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
12.59 | 16129372 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.34 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Benzene |
7.50 | 12562636 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
7.50 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
3.94 | 16752155 |
MESH:D014605 |
Uveitis |
|
Dexamethasone |
4.15 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Cisplatin |
3.97 | 15577323 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
3.92 | 12125929 |
MESH:D014657 |
Vasculitis |
|
Heparin |
5.41 | 20337814 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
4.54 | 16837676 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
2.95 | 14671159 15869587 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.43 | 16761959 |
MESH:D014839 |
Vomiting |
|
Cisplatin |
4.05 | 11897121 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
4.88 | 16343187 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.58 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.40 | 16287080 |